Joseph A Markenson

Summary

Affiliation: Hospital for Special Surgery
Country: USA

Publications

  1. ncbi Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort
    Joseph A Markenson
    Joan and Sanford Weill Medical College of Cornell University, Hospital for Special Surgery, New York, NY 10221, USA
    J Clin Rheumatol 19:317-23. 2013
  2. doi Rheumatic manifestations of endocrine diseases
    Joseph A Markenson
    Joan and Sanford Weill Medical College of Cornell University, Hospital for Special Surgery, New York, New York 10021, USA
    Curr Opin Rheumatol 22:64-71. 2010
  3. doi Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry
    Joseph A Markenson
    Hospital for Special Surgery, New York, NY 10021, USA
    J Rheumatol 38:1273-81. 2011
  4. ncbi Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study
    Allan Gibofsky
    Department of Rheumatology, Hospital for Special Surgery, New York, NY, USA
    Curr Med Res Opin 22:169-83. 2006
  5. doi Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries
    Allan Gibofsky
    Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    J Rheumatol 38:21-8. 2011
  6. doi Rheumatic manifestations of endocrine disease
    Soumya D Chakravarty
    Hospital for Special Surgery, Weill Cornell Medical College, New York, NY 10021, USA
    Curr Opin Rheumatol 25:37-43. 2013
  7. ncbi Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial
    Joseph A Markenson
    Hospital for Special Surgery, New York, NY, USA
    Clin J Pain 21:524-35. 2005
  8. ncbi Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005

Detail Information

Publications8

  1. ncbi Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort
    Joseph A Markenson
    Joan and Sanford Weill Medical College of Cornell University, Hospital for Special Surgery, New York, NY 10221, USA
    J Clin Rheumatol 19:317-23. 2013
    ..In rheumatoid arthritis (RA), there is discordance between patient and physician assessments of disease severity and treatment response...
  2. doi Rheumatic manifestations of endocrine diseases
    Joseph A Markenson
    Joan and Sanford Weill Medical College of Cornell University, Hospital for Special Surgery, New York, New York 10021, USA
    Curr Opin Rheumatol 22:64-71. 2010
    ..Musculoskeletal complaints accompanying or as a result of endocrine disorders are common and have been well described. This review re-examines these associations in light of newer information on biology and genetics...
  3. doi Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry
    Joseph A Markenson
    Hospital for Special Surgery, New York, NY 10021, USA
    J Rheumatol 38:1273-81. 2011
    ..To evaluate persistence with anti-tumor necrosis factor (TNF) therapy and predictors of discontinuation in patients with rheumatoid arthritis (RA)...
  4. ncbi Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study
    Allan Gibofsky
    Department of Rheumatology, Hospital for Special Surgery, New York, NY, USA
    Curr Med Res Opin 22:169-83. 2006
    ..RADIUS provides a snapshot of use patterns, effectiveness, and safety of DMARDs, biologics, and combination therapies used to manage RA in clinical practice...
  5. doi Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries
    Allan Gibofsky
    Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    J Rheumatol 38:21-8. 2011
    ....
  6. doi Rheumatic manifestations of endocrine disease
    Soumya D Chakravarty
    Hospital for Special Surgery, Weill Cornell Medical College, New York, NY 10021, USA
    Curr Opin Rheumatol 25:37-43. 2013
    ..Musculoskeletal complaints are a feature of several endocrine diseases. This review will update clinicians on their association, presentation, and treatment...
  7. ncbi Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial
    Joseph A Markenson
    Hospital for Special Surgery, New York, NY, USA
    Clin J Pain 21:524-35. 2005
    ....
  8. ncbi Role of biological agents in immune-mediated inflammatory diseases
    Petros Efthimiou
    Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    South Med J 98:192-204. 2005
    ..Their role is currently being defined in other autoimmune disorders such as uveitis, sarcoidosis, interstitial lung disease, vasculitis, inflammatory myopathies, graft-versus-host disease, and Sjögren syndrome...